Advertisement

Topics

Latest "twoXAR" News Stories

13:07 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "twoXAR" found in our extensive news archives from over 250 global news sources.

More Information about twoXAR on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about twoXAR for you to read. Along with our medical data and news we also list twoXAR Clinical Trials, which are updated daily. BioPortfolio also has a large database of twoXAR Companies for you to search.

Showing "twoXAR" News Articles, all 14

Relevant

TwoXAR Lands $10M to Ramp Up AI-Based Drug Discovery Work

Drug discovery startup twoXAR has raised $10 million in funding to support its efforts to build a pipeline of drug candidates found by its proprietary artificial intelligence technology. SoftBank Ventures led the Series A round of financing, and was joined by the Andreessen Horowitz Bio Fund and OS Fund. Palo Alto, CA-based twoXAR has developed […]


Series A lands $10mm for twoXAR

TwoXAR Inc. (using artificial intelligence in drug discovery) raised $10mm in a Series A financing led by SoftBank Ventures, ...

Seed round brings in $3.4mm for twoXAR

One-year-old twoXAR (artificial intelligence-based drug discovery) raised $3.4mm in seed financing led by Andreessen Horowitz...


AI Drug Developer TwoXAR Raises $10m In Series A

Californian biopharma, TwoXAR, which is using a computational platform to identify drug candidates, de-risks opportunities through preclinical studies, and progresses...   

AI company twoXAR raises $10M series A

Bioinformatics startups twoXAR bags $10M in Series A

The company, which is using an AI-based platform to comb through drug candidates in a much shorter time than traditional approaches require just raised $10 million.

Bioinformatics startup twoXAR bags $10M in Series A

The company, which is using an AI-based platform to comb through drug candidates in a much shorter time than traditional approaches require, just raised $10 million.

SoftBank Ventures Leads $10M Investment in AI-Driven Drug Discovery Company twoXAR

Andreessen Horowitz and OS Fund participate in Series A investment which will be used to build a portfolio of drug programs through biopharmaceutical partnerships twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that it has raised $10 million in Series A financing led by SoftBank Ventures, a SoftBank Group...

Seattle Genetics Says Adcetris Sets New Standard In Frontline Lymphoma

The market for a new FDA-approved indication in frontline classical Hodgkin lymphoma could be worth $650m to $750m, some analysts...   

Excitement Over MS Stem Cell Transplant 'Game Changer' Data

An international trial has demonstrated that HSCT was more effective than standard drugs for people with highly active relapsing-remitting multiple...    

Merger Buzz Boosts Shares Of India's Troubled Fortis

Shares of Indian hospital chain Fortis Healthcare have risen some 16% in the past month, fuelled by investor hopes of...    

AI driven biopharmaceutical startup raises $10M in series A financing

twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced that it has raised $10 million in Series A financing led by SoftBank Ventures, a SoftBank Group early stage venture capital arm. Joining SoftBank Ventures is the Andreessen Horowitz Bio Fund and OS Fund. The pr...

Probably Relevant

Twoxar Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryTwoxar Inc Twoxar is an artificial intelligencedriven drug discovery company that develops novel drug candidates. The company's drug discovery technology platform evaluates public and proprietary datasets to identify high probability drugdisease matches based on orders of magnitude. Its research programs include gene expression, proteininteraction, chemical structure, MOA, and clinical data...

Twoxar Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15032018] Prices from USD $250

SummaryTwoxar Inc Twoxar is an artificial intelligencedriven drug discovery company which develops novel drug candidates. Its drug discovery technology platform evaluates public and proprietary datasets to identify high probability drugdisease matches based on orders of magnitude. The company builds its own pipeline of therapeutic candidates across diseases as well as collaborates with biotechnolo...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks